Stock INSP INSPIRE MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Inspire Medical Systems, Inc.

Equities

INSP

US4577301090

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-23 pm EDT 		5-day change 1st Jan Change
233.9 USD +3.87% Intraday chart for Inspire Medical Systems, Inc. +5.55% +14.99%
Apr. 19 RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target MT
Apr. 18 Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing MT

Evolution of the average Target Price on Inspire Medical Systems, Inc.

Price target over the last 5 years

History of analyst recommendation changes

0b8054c6f0da7.zEKeNu8RiV0Rdrk_s0kpsC86OV-R48aymb68oF7HO_A.thbuf5tJsXB5L_JF-C5C5FxRTjLIvPGC18T4ySmGCaCpNPty12HvNncl8A~f09e71fca8e8cb797cd03ba711222028

Analyst Recommendations on Inspire Medical Systems, Inc.

RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target MT
Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing MT
Inspire Medical Systems Insider Sold Shares Worth $8,203,581, According to a Recent SEC Filing MT
Morgan Stanley Initiates Inspire Medical Systems at Overweight Rating With $250 Price Target MT
UBS Adjusts Inspire Medical Systems Price Target to $265 From $220, Maintains Buy Rating MT
Mizuho Adjusts Price Target on Inspire Medical Systems to $250 From $225, Maintains Buy Rating MT
Jefferies Initiates Inspire Medical Systems With Buy Rating, Price Target is $245 MT
Stifel Downgrades Inspire Medical Systems to Hold From Buy, Price Target is $210 MT
Truist Securities Raises Price Target on Inspire Medical Systems to $260 From $240, Maintains Buy Rating MT
Wells Fargo Downgrades Inspire Medical Systems to Equalweight From Overweight, Cuts Price Target to $187 From $245 MT
Truist Adjusts Price Target on Inspire Medical Systems to $240 From $260, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Inspire Medical Systems to $245 From $330, Maintains Overweight Rating MT
Stifel Cuts Price Target on Inspire Medical Systems to $250 From $350, Maintains Buy Rating MT
BofA Slashes Price Target on Inspire Medical Systems to $180 From $355, Keeps Buy Rating MT
UBS Adjusts Inspire Medical Systems Price Target to $322 From $405, Maintains Buy Rating MT
UBS Adjusts Inspire Medical Systems Price Target to $405 From $395, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Inspire Medical Systems to $330 From $315, Maintains Overweight Rating MT
Truist Securities Adjusts Price Target on Inspire Medical Systems to $380 From $360, Maintains Buy Rating MT
Stifel Adjusts Price Target on Inspire Medical Systems to $350 From $300, Maintains Buy Rating MT
BofA Securities Raises Price Target on Inspire Medical Systems to $355 From $310, Maintains Buy Rating MT
UBS Adjusts Inspire Medical Systems Price Target to $395 From $304, Maintains Buy Rating MT
Piper Sandler Raises Inspire Medical Systems' Price Target to $340 From $315, Keeps Overweight Rating MT
Keybanc Adjusts Price Target on Inspire Medical Systems to $335 From $321, Keeps Overweight Rating MT
Piper Sandler Adjusts Inspire Medical Systems' Price Target to $315 From $305, Keeps Overweight Rating MT
UBS Adjusts Inspire Medical Systems Price Target to $304 From $300, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
225.2 USD
Average target price
253.8 USD
Spread / Average Target
+12.68%
High Price Target
285 USD
Spread / Highest target
+26.54%
Low Price Target
187 USD
Spread / Lowest Target
-16.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Inspire Medical Systems, Inc.

RBC Capital Markets
Morgan Stanley
UBS
Mizuho Securities
Jefferies & Co.
Stifel Nicolaus
Truist Securities
Wells Fargo Securities
BofA Securities
Piper Sandler
KeyBanc Capital Markets
Goldman Sachs
Wolfe Research
SVB Leerink
Berenberg Bank
JPMorgan Chase
Lake Street

Ratings for Inspire Medical Systems, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. INSP Stock
  4. Consensus Inspire Medical Systems, Inc.